Gyre Therapeutics GYRE
NASDAQ GYRE
$7.11 +0.11 (+1.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Price to Earnings (2011 - 2025)

Updated

Gyre Therapeutics' (GYRE) Price to Earnings stood at 253.71 in Q4 2025, up 193.6% from 86.41 a year earlier and up 55.8% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Price to Earnings (2011 - 2025) Analysis & Trends

For FY2025, Gyre Therapeutics' Price to Earnings came in at 128.24, up 48.4% from FY2024.

  • Across earlier years, Price to Earnings came in at 86.41 in FY2024 and 8.69 in FY2022.
  • Quarterly Price to Earnings has ranged from 0.42 in Q1 2023 to 397.59 in Q2 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 162.80 (Q3 2025), 397.59 (Q2 2025) and 93.30 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Gyre Therapeutics 753.90 Mn 556.61 Mn 26.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 253.71
Sep 30, 2025 162.80
Jun 30, 2025 397.59
Mar 31, 2025 93.30
Dec 31, 2024 86.41
Mar 31, 2023 0.42
Dec 31, 2022 8.69
Sep 30, 2022 1.33
Jun 30, 2011 66.02
Mar 31, 2011 46.20
API Access

Gyre Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=GYRE&period=max&api_key=YOUR_API_KEY